Here, we talk with David Davies, whose appointment as the new head of development at Medherant marks the company’s move into clinical development of the ibuprofen TEPI Patch.
1. Could you briefly describe yourself?
Meet the maker: EPM talks to David Davies
Here, we talk with David Davies, whose appointment as the new head of development at Medherant marks the company’s move into clinical development of the ibuprofen TEPI Patch.
Published:
|
2 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.